ATE235243T1 - Verwendung von 11-substituierten steroiden zur herstellung von medikamenten mit unterschiedlicher östrogenischen wirkung - Google Patents

Verwendung von 11-substituierten steroiden zur herstellung von medikamenten mit unterschiedlicher östrogenischen wirkung

Info

Publication number
ATE235243T1
ATE235243T1 AT97403115T AT97403115T ATE235243T1 AT E235243 T1 ATE235243 T1 AT E235243T1 AT 97403115 T AT97403115 T AT 97403115T AT 97403115 T AT97403115 T AT 97403115T AT E235243 T1 ATE235243 T1 AT E235243T1
Authority
AT
Austria
Prior art keywords
estrogenic effects
substituted steroids
formula
medications
substituted
Prior art date
Application number
AT97403115T
Other languages
English (en)
Inventor
Yamina Bouali
Francois Nique
Daniel Philibert
Jean-Georges Teutsch
De Velde Patrick Van
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE235243T1 publication Critical patent/ATE235243T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97403115T 1996-12-23 1997-12-22 Verwendung von 11-substituierten steroiden zur herstellung von medikamenten mit unterschiedlicher östrogenischen wirkung ATE235243T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615828A FR2757399B1 (fr) 1996-12-23 1996-12-23 Application de composes steroides substitues en 11 pour la fabrication de medicaments ayant une activite estrogene dissociee

Publications (1)

Publication Number Publication Date
ATE235243T1 true ATE235243T1 (de) 2003-04-15

Family

ID=9498982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97403115T ATE235243T1 (de) 1996-12-23 1997-12-22 Verwendung von 11-substituierten steroiden zur herstellung von medikamenten mit unterschiedlicher östrogenischen wirkung

Country Status (7)

Country Link
US (2) US5981516A (de)
EP (1) EP0850647B1 (de)
JP (1) JP4263264B2 (de)
AT (1) ATE235243T1 (de)
DE (1) DE69720160T2 (de)
ES (1) ES2196281T3 (de)
FR (1) FR2757399B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757519B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
US6172052B1 (en) 1998-12-04 2001-01-09 Research Triangle Institute 17β-acyl-17α-propynyl-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
DE19929715A1 (de) 1999-06-24 2000-12-28 Schering Ag 11ß-langkettig-substituierte Estratriene, Verfahren zur Herstellung , pharmazeutische Präparate, die diese 11ß-langkettig-substituierten Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
CA2623883C (en) 2005-09-27 2013-01-29 Paradigm Spine, Llc Interspinous vertebral stabilization devices
US20080103116A1 (en) * 2006-11-01 2008-05-01 Jennings-Spring Barbara L Method of treatment and compositions of D-chiro inositol and phosphates thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
US4978657A (en) * 1981-01-09 1990-12-18 Roussel Uclaf Novel 11β-substituted-19-nor-steroids
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2618783B1 (fr) * 1987-07-30 1991-02-01 Roussel Uclaf Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
US4925816A (en) * 1987-08-29 1990-05-15 Ngk Insulators, Ltd. Novel solid solution, heat-resistant sintered body and method of producing the same
FR2620707B1 (fr) * 1987-09-18 1989-12-08 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
US5981516A (en) 1999-11-09
JPH10182466A (ja) 1998-07-07
ES2196281T3 (es) 2003-12-16
JP4263264B2 (ja) 2009-05-13
EP0850647B1 (de) 2003-03-26
EP0850647A1 (de) 1998-07-01
FR2757399B1 (fr) 1999-12-17
US6011026A (en) 2000-01-04
DE69720160D1 (de) 2003-04-30
FR2757399A1 (fr) 1998-06-26
DE69720160T2 (de) 2003-11-13

Similar Documents

Publication Publication Date Title
LT97074A (en) Sterol compositions from pulping soap
GEP20022766B (en) Steroid Sulphatase Inhibitors
DE69737510D1 (de) Verwendung eines unverkapselten anti-krebs-wirkstoffs zur herstellung einer zubereitung zur behandlung von neoplasmen durch inhalation
ATE320259T1 (de) Verwendung von oestrogenverbindungen zur steigerung der libido bei frauen
DE69432752D1 (de) Zusammensetzung zur substitutionstherapie, die mindestens ein progestogen und mindestens ein oestrogen enthält
KR910004653A (ko) 스테로이드 5-α-환원효소의 억제제로서의 7-케토 또는 히드록시 3,5-디엔 스테로이드
DE3782468T2 (de) Verfahren zur behandlung von maennlicher sexueller dysfunktion.
ATE235243T1 (de) Verwendung von 11-substituierten steroiden zur herstellung von medikamenten mit unterschiedlicher östrogenischen wirkung
KR880012633A (ko) C_17 내지 C_20 리아제 억제제로서 유용한 17β-(사이클로프로필아미노)안드로스트-5-엔-3β-올 및 관련 화합물
NZ236614A (en) Therapeutic composition containing corticosteroid and igf-i, the igf-i reducing or preventing the adverse effects of the corticosteroid
DE69314570D1 (de) Verfahren zur Herstellung Taurin-konjugierter Gallensäure
ES546372A0 (es) Procedimiento para preparar nuevos esteroides sustituidos en posicion 10.
DE69517356T2 (de) Verwendung von aromatischen Steroiden, die in der 3-Stelle bei einer disubstituierte-aminoalkoxy Kette substituiert sind, zur Herstellung eines Medikaments zur Kontrolle der Fertilität, insbesondere männlicher Fertilität
KR880002532A (ko) 플래티넘 유도체 및 암 치료제(Platinum Derivatives and Cancer Treatments)
DE69230069T2 (de) Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms
Yahr The role of aromatization in androgen stimulation of gerbil scent marking
ATE175419T1 (de) Verfahren zur herstellung von 4-amino-delta 4-3- ketosteroiden via 4-nitro-delta-4-3-ketosteroiden
DE69704272D1 (de) Vitamin d analoga und verfahren zu ihrer herstellung
TW334437B (en) Process for the preparation of streptogramins
Nutting et al. Estradienes and 2-oxaestradienes. Potent oral anabolic-androgenic agents
GB9218771D0 (en) Synergistic composition for dermatitis treatment
DE69213268D1 (de) Verfahren zur Herstellung eines feinen dendritischen Pulvers und nach diesem Verfahren erzeugtes Pulver
Walker et al. The comparative potency of various steroids to complete the priming process for lordosis in guinea pigs
Croxatto et al. Effect of RU486 on development and implantation of rat embryos
MY109207A (en) Subcutaneous implants based on nomegestrol derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties